Treatment

Displaying 11 - 20 of 60

Tool suits prognosis and choice of therapy for RA

In rheumatoid arthritis, antibodies are formed that affect the inflammation in the joints. In an article published today in the journal Annals of the Rheumatic Diseases, researchers at Uppsala University show that antibodies against the cartilage protein collagen II are associated with a good prognosis. “Analysing these antibodies, in combination with other relevant antibodies, could be used for predicting prognosis and choosing therapy for rheumatoid arthritis patients,” says Professor Johan Rönnelid who has led the study.
23rd March 2017

CoreValve Evolut Pro valve receives FDA approval

CoreValve Evolut Pro valve receives FDA approval
Medtronic has announced FDA approval and U.S. launch of the CoreValve Evolut PRO valve for the treatment of severe aortic stenosis for symptomatic patients who are at high or extreme risk for open heart surgery. The approval comes on the heels of new 30-day clinical data that was unveiled at the ACC 66th Annual Scientific Session, which showed high survival, low rates of stroke, minimal paravalvular leak (PVL) and hemodynamics for the self-expanding valve.
23rd March 2017

Personalised radiotherapy may help beat bone tumours

Researchers in the UK have developed a personalised and more effective approach to treating cancer patients with bone metastases. The team used radiobiological models to calculate the absorbed radiation doses needed to eradicate all the bone lesions in patients with castration-resistant prostate cancer (CRPC). They put forward a new model to predict the decrease in tumour size in patients treated with molecular radiotherapy.
20th March 2017


Implantable pump delivers drugs directly into the brain

Implantable pump delivers drugs directly into the brain
Flowonix Medical of New Jersey, and Colorado-based Cerebral Therapeutics, announced the first patients implanted with the Prometra. ADDRESS is the first multi-center dose ranging clinical study assessing intracerebroventricular (ICV) delivery of the drug valproate (valproate sodium) in patients with focal seizures, with temporal lobe onset with or without secondary generalisation.
17th March 2017

Nasal nebulizer gets green light in Europe

Nasal nebulizer gets green light in Europe
MedInvent, LLC has announced CE Marking of its patented intranasal delivery device, the NasoNeb II Nasal Nebulizer, manufactured, marketed and sold in the United States since 2009. MedInvent is also pleased to announce its first EU distribution contract with Vedise Hospital in Rome, to market the NasoNeb System in Italy, San Marino and Vatican City. Vedise Hospital has marketed ENT products for over 20 years, serving Otolaryngologists in Italy.
15th March 2017

Electricity improves short-term memory

Electricity improves short-term memory
Scientists have uncovered a method for improving short-term working memory, by stimulating the brain with electricity to synchronise brain waves. Researchers at Imperial College London found that applying a low voltage current can bring different areas of the brain in sync with one another, enabling people to perform better on tasks involving working memory.
14th March 2017

A promise for patients with damaged corneas

A promise for patients with damaged corneas
Researchers working as part of the University of Georgia’s Regenerative Bioscience Center have developed a new way to identify and sort stem cells that may one day allow clinicians to restore vision to people with damaged corneas using the patient’s own eye tissue. They published their findings in Biophysical Journal. The cornea is a transparent layer of tissue covering the front of the eye, and its health is maintained by a group of cells called limbal stem cells.
14th March 2017

Researchers clarify chemo resistance

Researchers clarify chemo resistance
Mayo Clinic scientists have identified a specific protein implicated in drug resistance, as well as a possible therapeutic tool. Their work appears in the EMBO Journal. The team led by Haojie Huang, Ph.D., a Mayo Clinic tumor biologist within Mayo Clinic's Center for Biomedical Discovery identified the role of FOXO1 in chemotherapy resistance. They also identified a potential therapeutic tool by engineering a peptide, which is a short segment of amino acids.
10th March 2017

MRI-powered mini-robots offer targeted treatment

MRI-powered mini-robots offer targeted treatment
Invasive surgical techniques - cutting through the breastbone for open heart surgery or making a large incision to inspect an abdominal tumor - allow physicians to effectively treat disease but can lead to sometimes serious complications and dramatically slow healing for the patient. Scientists instead want to deploy dozens, or even thousands of tiny robots to travel the body's venous system as they deliver drugs or a self-assembled interventional tool.
9th March 2017

Pressure switch ensures safety levels for soft tissue repair machine

Pressure switch ensures safety levels for soft tissue repair machine
  The PHYSIOLAB Thermal Compression unit is an intelligent clinical toolkit to support physiotherapists, surgeons and clinicians in accelerating soft tissue repair following injury, trauma or surgery, preventing injury in advance of activity and aiding recovery after exercise.
8th March 2017


Treatment documents

Datasheets
Whitepapers

Sign up to view our publications

Sign up

Sign up to view our downloads

Sign up

LASER World of PHOTONICS 2017
26th June 2017
Germany Messe Munchen